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Preamble 
It is becoming more apparent each day that despite a strong 
national commitment to excellence in health care. the re- 
sources and personnel are finite. It is, therefore. appropriate 
that the medical profession examine the impact of develop- 
ing technology on the practice and cost of medical care. 
Such analyses, carefully conducted, could potentially impact 
on the cost of medical care without diminishing the effec- 
tiveness of that care. 
To this end, the American College of Cardiology and the 
American Heart Association in 1980 established a Task 
Force on Assessment of Diagnostic and Therapeutic Cardio- 
vascular Procedures with the following charge: 
The Task Force of the American College of Cardiology and 
the .4merican Heart Association shall define the role of 
specific noninvasive and invasive procedures in the diag- 
nosis and management of cardiovascular disease. 
The Task Force shall address, when appropriate. the contri- 
bution. uniqueness, sensitivity, specificity. indications, 
Address for reorints: Mr. David J. Feild. Associate Executive Vice 
President. American College of Cardiology, 911 I Old Georgetown Koad. 
Bethesda, Maryland 20X13. 
contraindications and cost-etfectiveness of such specific 
procedures. 
The Task Force shall include a Chairman and four mem- 
bers. two representatives from the American Heart 
Association and two representatives from the American 
College of Cardiology. The Task Force may select ad 
hoc members as needed upon the approval of the Presi- 
dents of both organizations. Recommendations of the 
Task Force are forwarded to the President of each orga- 
nization. 
The members of the Task Force are: Roman W. De- 
Sanctis. MD, Harold T. Dodge, MD. T. Joseph Reeves, MD. 
Sylvan Lee Weinberg, MD and Charles Fisch. MD. Chair- 
man. 
This document was reviewed by the officers and other 
responsible individuals of the two organizations and received 
final approval in October 1988. It is being published simulta- 
neously in Cirdrrtion and the Jownul qf‘ the Atnerican 
Collcgr of’ Cudiology. Both the potential impact of this 
document on the practice of cardiology and some of its 
unavoidable shortcomings are clearly set out in the 
introduction. 
Charles Fisch, MD. FACC 
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I. Introduction 
A. Dejining the Role of Ambulatory 
Electrocardiographic Systems in Clinical 
Decision Making 
With the introduction in 1961 of a method for recording 
the electrocardiogram (ECG) from an ambulatory subject 
over extended time periods, a new electrocardiology was 
initiated. Instrumentation considerations dominated the de- 
velopment of the technology over the subsequent years. A 
broad range of advances and improvements were made in 
recording fidelity, equipment size and weight and data 
acquisition and analysis systems. The periods of time over 
which the signal can be recorded lengthened progressively. 
The capability for noncontinuous recording, triggered by 
either the subject or arrhythmia occurrence, became avail- 
able. Automated off-line and real-time analysis systems were 
developed to decrease technician time or to provide more 
prompt reporting, or both, and, purportedly, to increase 
accuracy. Ambulatory ECG recording and review systems 
continue to evolve, and improvements in the analysis and 
editing capabilities of commercial systems are being intro- 
duced with some frequency. 
With maturing of the ambulatory ECG instrumentation, 
clinical applications expanded. In addition to the use of 
ambulatory ECG recordings for the confirmation of arrhyth- 
mias as the cause of symptoms occurring during daily 
activities, the technology is being applied to the prediction of 
future cardiac events, detection of myocardial ischemia and 
documentation of the therapeutic efficacy of antiarrhythmic 
and anti-ischemic agents. With this increased utilization has 
come the need to define the role of ambulatory electrocar- 
diography more precisely. As the applications broaden and 
encompass elements of the ECG signal other than rhythm, 
the quantitative aspects of system performance become 
more critical. When a test is being used for diagnosis, as a 
guide to therapeutic management or for prognostic purposes, 
knowledge of its predictive value is essential. The predictive 
value, in turn, depends on the sensitivity and specificity of 
the test and the prevalence of the disease in the population 
group to which the person being tested belongs. For accu- 
racy in these more diverse applications, more complete 
information about possible technical errors, physiologic or 
artifactual influences on the test and the distribution of 
normal and abnormal results is critical to the effective use of 
the test to solve clinical problems. 
Ambulatory electrocardiography as an aid to clinical 
decision-making was the focus of the Subcommittee deliber- 
ations. Therefore, this report is based on the most frequently 
stated clinical reasons for ordering an ambulatory ECG. 
Under each broad clinical indication, further subgrouping is 
accomplished and each subgroup is assigned to one of the 
following classes: 
Class I: Conditions for which (or patients for whom) 
there is general agreement that an ambulatory ECG is a 
useful and reliable test. 
Class II: Conditions for which (or patients for whom) an 
ambulatory ECG is frequently used but there is a divergence 
of opinion with respect to its utility. 
Class III: Conditions for which (or patients for whom) 
there is general agreement that an ambulatory ECG is not a 
useful test. 
When appropriate, specific types of systems may be 
stated to be the most appropriate for a particular clinical 
indication. 
B. Assumptions Underlying the 
Subcommittee Report 
Because of the numerous differences in the recording and 
analysis systems and the absence of a method for intersys- 
tern comparisons, the Subcommittee developed the indica- 
tion assessments on the assumptions that for each system 1) 
electrical signals are being reliably recorded, retrieved and 
displayed; 2) the accuracy of the system being employed is 
known relative to the purposes for which it is being em- 
ployed; and 3) verification of the accuracy of system func- 
tioning is available as required. Recommendations for tech- 
nologically accurate and repeatable studies and quality 
control in the analysis of ambulatory ECGs have been put 
forth previously (1). 
The generic term ambulatory electrocardiogram (or am- 
bulatory ECG) is used to indicate all forms of continuous or 
intermittent recording as well as transtelephonic data trans- 
fer. 
The Subcommittee has not made any recommendations 
regarding resources required for the provision of adequate 
ambulatory ECG services or for the training of the individ- 
uals, physicians and technical personnel responsible for 
acquiring and interpreting the data. In general, however, the 
Subcommittee supports the training requirements for cardio- 
vascular fellows as outlined in the American College of 
Cardiology Bethesda Conference on Optimal Electrocardi- 
ography (2). The Subcommittee considers the most critical 
concerns to be those surrounding knowledge of the charac- 
teristics of the system or systems being utilized by any 
provider of ambulatory ECG services. It needs to be recog- 
nized that all systems are dependent, to variable degrees, on 
the skills and compulsion of the technical personnel as well 
as the physicians making the final report. Totally automated 
systems have not yet achieved a documented accuracy 
sufficient to eliminate the need for human overview. 
In virtually all of the situations in which the role of 
ambulatory electrocardiography is discussed, it is assumed 
that the patients to receive the test have undergone a 
complete history and physical examination and that the 
usefulness and likely yield of the test have been carefully 
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considered. The decision to perform an ambulatory ECG 
and the interpretation of its results are rarely done in 
isolation without consideration of other factors relevant to 
the individual patient. When appropriate, other invasive and 
noninvasive tests should be performed before use of an 
ambulatory ECG is considered. Given the diversity of uses 
of ambulatory electrocardiography, it is impossible to pro- 
vide a “cookbook” listing of the precise usefulness of 
ambulatory recordings in all circumstances. There may be 
situations that have been given a Class I categorization for 
which an ambulatory ECG is not necessary or appropriate 
and other circumstances with a Class III rating for which the 
test is both clinically appropriate and useful. 
Finally, as with any test, the role of ambulatory electro- 
cardiography is undergoing evaluation and the recommenda- 
tions made here may undergo continuous and at times 
striking changes so that the guidelines given at this time may 
not be applicable as additional information becomes avail- 
able. The American College of Cardiology and the American 
Heart Association recognize the fact that the ultimate judg- 
ment regarding the propriety of any specific procedure is the 
responsibility of the physician caring for the patient. The 
guidelines should not be considered all inclusive or exclusive 
of other methods that may be available for the care of the 
individual patient. 
II. Instrumentation and Systems 
The purpose of this section is to describe the capabilities 
and characteristics of systems used for ambulatory electro- 
cardiography. Instrumentation includes devices for acquisi- 
tion, analysis and display of long-term ECG recordings. 
Emphasis is placed on a general description of system types 
and their characteristics rather than on specific perform- 
ance standards. These have been reviewed in a previous re- 
port (I). 
A. Recording Systems 
The primary goal of ambulatory electrocardiography is to 
document and characterize occurrences of random, sponta- 
neous, sleep-related, emotion- or stress-induced abnormal 
cardiac electrical behavior in the ambulatory subject. To 
capture these often rare and occasionally life-threatening 
events and to correlate symptoms with rhythm disturbances 
or ST segment shifts during activity, it is necessary to record 
or observe cardiac electrical behavior in a continuous man- 
ner for long periods of time and during the course of the 
normal daily activities of the patient. Numerous recording 
devices have evolved to meet the needs for ambulatory 
electrocardiography and include two basic families: contin- 
LKM~ recorders and intermittent recorders. 
Continuous recorders. These are small devices that typi- 
cally include two ECG amplifiers and an analog tape re- 
corder for permanently storing the continuous records. 
Amplifier characteristics are similar to those used in conven- 
tional ECG recording systems (high input impedance, high 
noise immunity, linear response, for example) although the 
frequency response of ambulatory devices is narrower. This 
fact limits fidelity of the recordings to the extent that high 
frequency notching and ST segment displacement may not 
be recorded or interpreted reliably in all systems. Most 
recorders use ‘/8 inch (0.32 cm) tape cassettes or ti inch (0.64 
cm) tape reels and record at very slow speeds (typically 
0.0625 inch [0.16 cm]/s) to achieve continuous recording 
over 24 h. Timing accuracy is based on precision of the tape 
drive motor and gearing and, in some cases, recording of 
timing signals along with the data. Event markers, provided 
on most units, consist of a button that is activated by the 
patient to document the occurrence of a symptom. The 
button introduces a recognizable artifact in the recording 
that. during playback, can be correlated with the patient’s 
symptoms. The recorders are compact, battery operable and 
wearable, thus permitting continuous data recording for 24 h 
and, importantly, during the normal daily activities of the 
patient. Recording and ground leads are placed to minimize 
noise and patient discomfort and to maximize signal infor- 
mation. 
All-digital wcording systsms. The advent of very high 
density semiconductor memory has led to the potential for 
all-digital recording systems. In these devices, the incoming 
amplified signals are digitized, encoded and stored in the 
solid state memory. In the presence of efficient and accurate 
coding algorithms, it is thus potentially possible to reproduce 
full disclosure records in addition to summaries of arrhyth- 
mia content. Primary advantages to be gained by such 
devices arc reduction in size, elimination of mechanical parts 
(electrical tape drive motor and gears). reduction in energy 
requirements (battery size) and improvement of signal to 
noise ratios (elimination of tape noise. both during recording 
and playback). These devices also provide the potential for 
adding on-board intelligence to analyze and process incom- 
ing data in real time. for example, to characterize or classify 
complex arrhythmia configurations, track heart rate, count 
premature ventricular complexes and other applications. 
These systems are referred to as real-time analysis ambula- 
tory systems. 
Intermittent recorders. The design philosophy of these 
recorders differs from that of continuous recorders. Al- 
though the hardware implementation of the two systems is 
similar, intermittent recorders are capable of recording only 
a limited number of short segments of data. Their purpose is 
to capture critical cardiac electrical behavior when the 
patient first detects the onset of symptoms (palpitation, 
dizziness. fast heart rate or other symptoms). 
liNn.stelephonic cupubility. Some recorders can provide 
transtelephonic transmission of signals directly to a central- 
ized analysis or interpretation facility. In this mode, the 
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patient may dial the facility, hold a transducer on the 
recorder to the phone mouthpiece and play back selected 
segments for interpretation. 
B. Review Systems 
Rapid playback and analysis capability. A variety of 
systems are available for analysis of 24 h continuous record- 
ings. These offer a wide range of data display and statistical 
summary options. Virtually all conventional tape systems 
utilize rapid playback (60x or 120~ real time) resulting in the 
potential for complete analysis of a tape in 15 to 30 min. The 
objectives of the analysis include determination of QRS 
complex configuration and frequency, reporting of data on 
heart rate, and detection and characterization of episodes of 
arrhythmias. The information is typically presented in tabu- 
lar form as well as in graphic forms such as displays of 
frequency distributions of arrhythmias and histograms of 
cycle length. In addition, during playback and analysis, 
segments of data containing arrhythmic events (isolated 
premature ventricular complexes, couplets, bigeminal epi- 
sodes or bursts of ventricular tachycardia) or potential 
ischemic events (ST segment depression or elevation), or 
both, may be printed as standard ECG strips. 
Full disclosure capability. Some systems provide a “full 
disclosure” capability in which a complete record of “every 
complex occurring for 24 h” is plotted on compressed time 
and voltage scales. Though the resolution of the full disclo- 
sure display is insufficient to detect subtle morphologic 
changes on a beat to beat basis, isolated premature com- 
plexes, sequences of premature ventricular complexes and 
ventricular tachycardia are clearly evident. Because time of 
day is either recorded or computed, episodes of abnormal 
cardiac activity can be correlated with patients’ observations 
of symptoms. In general, systems that provide for full 
disclosure are preferred because the physician in charge of 
the patient can visually scan the record as indicated. 
Interactive capability. In addition to a wide range of 
analysis and display formats, systems have a spectrum of 
capabilities for automatic or manual interaction during proc- 
essing. This is a necessity because no machine provides 
perfect discrimination between “unusual” but physiologic 
signals and noise or artifact. Even when precautions are 
observed for skin preparation and electrode placement, 
noise introduced by muscle potentials, patient or lead mo- 
tion or electrical interference precludes the possibility of 
perfect, low noise recordings for 24 h. The better systems of 
analysis can detect “difficult” signal segments and provide 
an operator with the raw signals, which can be ignored, 
classified or simply displayed in hard copy form. Other 
systems permit interactive modification of detection and 
classification parameters in order to tailor the processing to 
specific requirements. 
III. Clinical Indications for Ambulatory 
Electrocardiography 
A. Assessment of Symptoms That May Be 
Related to Rhythm Disturbances of the Heart 
General considerations 
One of the primary and most widely accepted uses of 
ambulatory electrocardiography is in determining whether 
patients’ symptoms of palpitation, dizziness, shortness of 
breath, syncope or other manifestations of cardiovascular 
dysfunction are related to cardiac arrhythmias. Although 
ECG recordings made in such patients during asymptomatic 
periods may occasionally yield important clues to the possi- 
ble cause of symptoms, in most cases such determination 
requires documentation of the spontaneous occurrence of 
symptoms in relation to arrhythmias. An ambulatory ECG 
showing no arrhythmia is of little value if the patient does 
not experience symptoms during the period of recording 
and if the recording, therefore, cannot exclude an arrhyth- 
mia as the cause of the symptoms. An ambulatory ECG 
demonstrating asymptomatic arrhythmias may give a 
clue to the cause of the patient’s symptoms but, because 
asymptomatic arrhythmias frequently occur in the general 
population, it is possible that these arrhythmias have little 
relevance to the patient’s symptoms. An ambulatory ECG 
that excludes arrhythmia as the cause of a patient’s symp- 
toms by showing no arrhythmia at the time of occurrence of 
a typical symptomatic episode may be as valuable as a 
recording clearly demonstrating a relation between the pa- 
tient’s symptoms and a cardiac rhythm disturbance. Al- 
though the 24 h ambulatory ECG is not likely to be clinically 
useful when symptoms are not expected to occur during 
the recording period, it remains an acceptable adjunctive 
procedure in certain situations such as syncope, where the 
low diagnostic yield is offset by the severe nature of the 
symptoms. 
Selection of patients for different recording devices. The 
need to record the ECG until symptoms occur causes the 
yield of useful information from ambulatory studies to be 
heavily dependent on patient selection (especially the fre- 
quency of occurrence of symptoms) and the type of system 
utilized. There are relatively few data from which to derive 
the sensitivity, specificity and cost-effectiveness of ambula- 
tory recordings in symptomatic patients. For patients who 
experience symptoms daily, a continuous 24 h ambulatory 
ECG generally provides useful information about the rela- 
tion between the symptoms and arrhythmias. However, 
most patients seeking medical attention do not have typical 
symptoms on a daily basis. In the early days of ambulatory 
electrocardiography it was often necessary to record the 
tracings for several or more consecutive days, and several 
studies (3,4) have demonstrated a need to record over a 
period of days to weeks or longer. The introduction of 
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patient-activated intermittent recorders and transtelephonic 
ECG capability have greatly aided the evaluation of such 
patients. and have made multiple day 24 h ambulatory 
ECGs a cost-ineffective procedure unless the patient’s 
symptoms include abrupt loss of consciousness. For pa- 
tients whose typical symptoms do not occur daily and are 
not incapacitating, transtelephonic devices would appear 
to be superior to a single 24 h recording (5). These devices 
are also more cost-effective than multiple 24 h recordings 
once the patient’s baseline arrhythmias have been charac- 
terized by a single conventional 24 h recording. When a 
patient’s symptoms are transient, devices with both contin- 
uously applied electrodes and a memory loop may be nec- 
essary. When transtelephonic ECG strips show no relation 
between a patient’s symptoms and an underlying arrhyth- 
mia, no further monitoring is required. When the strips 
show a definite correlation between symptoms and an 
arrhythmia. an additional routine 24 h ambulatory ECG 
may be valuable even if no symptoms are anticipated 
during the recording period. In such patients the 24 h 
recording helps to assess the frequency of occurrence of 
asymptomatic episodes of arrhythmias similar to those re- 
corded at the time of symptoms. These recordings frequently 
help to determine whether the arrhythmia causing symptoms 
is the only arrhythmia present or whether the patient has 
frequent episodes of similar arrhythmias that are asympto- 
matic. 
In considering the appropriateness of ambulatory elec- 
trocardiography in an individual patient, the likelihood 
that the patient’s symptoms are due to a cardiac arrhythmia 
must be considered. Symptoms such as palpitation have a 
high likelihood of being due to an arrhythmia; therefore. 
ambulatory electrocardiography should be considered 
early in the evaluation of patients with this symptom. In 
contrast, episodic shortness of breath is much less likely to 
be caused by an arrhythmia. Ambulatory electrocardio- 
graphy should be utilized in patients with this symptom 
only when other causes have been considered and ex- 
cluded. and only when the symptom is paroxysmal and has 
some probability of being related to a cardiac rhythm 
disturbance. 
Classification of indications for ambulatory 
electrocardiography to assess symptoms possibly 
related to rhythm disturbances 
Class I: Palpitation, syncope, dizziness. 
Class II: Shortness of breath, chest pain or fatigue (not 
otherwise explained, episodic and strongly suggestive of an 
arrhythmia as the cause because of a relation of the symptom 
with palpitation). 
Class III: Symptoms not reasonably expected to be due 
to arrhythmia. 
General considerations 
Although not widely appreciated, beat to beat changes in 
heart rate or cycle length (RR intervals) may contain useful 
information for the diagnosis of certain conditions. The 
ambulatory ECG is ideally suited to assess RR intervals over 
long periods of time. During sinus rhythm, beat to beat 
differences in cardiac cycle length occur because of changes 
in autonomic tone. In situations of complete cardiac dener- 
vation such as cardiac transplantation. a mild sinus tachy- 
cardia at rest is present with no beat to beat difference in 
cardiac cycle length. In these patients. changes in cardiac 
cycle length occur over periods of several minutes or longer. 
probably in response to circulating catecholamines. A simi- 
lar situation occurs with neuropathies commonly seen with 
advanced diabetes mellitus (6). Patients with sleep apnea 
syndrome develop a marked sudden increase in vagal tone at 
the time of their apnea, probably related to performing a 
Mueller maneuver. Such patients experience marked brady- 
cardia during episodes of apnea and show a characteristic 
cyclical RR interval pattern on properly analyzed ECG 
recordings. The ambulatory ECG. when evaluated for RR 
interval information, is extremely useful for diagnosing 
obstructive sleep apnea (7). Although the systems providing 
for the assessment of RR interval characteristics are not 
widely available at this time, they are in production and will 
soon be available for general clinical use. 
Prognostic information for patients with coronary artery 
disease recently has been observed to be available from the 
study of RR variability on the ambulatory ECG. Prospective 
studies of patients after myocardial infarction have shown 
that heart rate variability may be a predictor of prognosis. 
independent of ventricular arrhythmias or left ventricular 
function (8.9). 
Classification of indications for ambulatory 
electrocardiography to assess RR interval 
characteristics 
Class I: Sleep apnea and visceral diabetic neuropathy 
(only when RR interval evaluation is performed). 
Class II: RR interval variability as a prognostic sign in 
coronary artery disease. 
Class III: None. 
C. Assessment of Risk in Patients With 01 
Without Symptoms of Awhythrnicr 
General considerations 
These individuals fall into two categories: those whose 
activities might endanger themselves or others if an arrhyth- 
mia occurred and those whose medical condition is associ- 
ated with a higher than usual frequency of life-threatening 
arrhythmias. 
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Specific considerations 
The asymptomatic individual whose sudden incapacitation 
could threaten the lives of others. The prototypic individual 
in this category is the airline pilot. Despite the potential 
adverse consequences of a sudden incapacitating arrhyth- 
mia, the frequency of events that could be predicted by 
ambulatory ECG recording is too low to justify testing. 
The asymptomatic patient about to embark on an exercise 
program. Premature ventricular complexes and even ven- 
tricular tachycardia, if detected by ambulatory electrocar- 
diography in asymptomatic patients without organic heart 
disease, have virtually no predictive value for future cardiac 
events (10). In the absence of additional data, there is little 
justification for ambulatory electrocardiography in this pa- 
tient group. 
The patient with known stable coronary artery disease and 
no prior myocardial infarction. In patients with coronary 
artery disease and no prior myocardial infarction, both 
frequent and complex forms of premature ventricular com- 
plexes indicate a higher risk for subsequent cardiac events 
(11). This increment in risk is almost entirely in the subgroup 
of patients with evidence of significant myocardial dysfunc- 
tion. The use of ambulatory electrocardiography in such 
patients, therefore, usually requires as an indication the 
presence of frequent and complex ventricular ectopic beats 
and evidence for impaired myocardial functioning. 
The postinfarction patient. Postinfarction patients with 
premature ventricular complexes have been stated to be at 
higher risk for cardiac events, even after correction for 
ejection fraction (12). Although routine performance of 
ambulatory ECGs after myocardial infarction may be ques- 
tioned on the basis of cost-effectiveness, there may be a 
reasonable medical justification for the study in this group of 
patients. 
The patient after bypass surgery or angioplasty. Limited 
information exists in regard to ambulatory ECG studies of 
patients after angioplasty or revascularization surgery. In 
general, such groups of patients probably have the same set 
of indications as those with known stable coronary disease 
without prior myocardial infarction. 
The postinfarction patient entering an exercise program. 
For the typical postinfarction patient entering an exercise 
program, 24 h electrocardiography appears to offer no infor- 
mation of value for clinical decision-making. 
Cardiomyopathies. Runs of ventricular tachycardia in 
patients with hypertrophic cardiomyopathy, whether or not 
associated with symptoms, constitute a higher risk for sud- 
den death (13). With therapy, the frequency of these tachy- 
cardias often can be reduced and survival improved (14). 
The diagnosis of hypertrophic cardiomyopathy is, therefore, 
an indication for an ambulatory ECG. 
Mitral valve prolapse. Patients who are symptomatic and 
who have documented mitral valve prolapse should be 
considered under the guidelines for the symptomatic patient. 
Neither asymptomatic premature ventricular complexes nor 
other asymptomatic arrhythmias in patients with mitral 
valve prolapse indicate a more grave prognosis in compari- 
son with that of patients without arrhythmias (15). In the 
absence of additional information, therefore, the presence of 
the diagnosis of mitral valve prolapse alone does not estab- 
lish the need for ambulatory ECG recordings. 
Classification of indications for ambulatory 
electrocardiography to assess risk of future cardiac 
events in patients with or without symptoms from 
arrhythmia 
Class I 
a. In the patient with idiopathic hypertrophic cardiomy- 
opathy, with or without symptoms. 
b. In the postmyocardial infarction patient with left ven- 
tricular dysfunction. 
Class II 
a. In the patient who has known stable coronary artery 
disease or who has undergone coronary bypass surgery or 
angioplasty and has evidence for myocardial dysfunction or 
arrhythmia. 
b. In the patient with Wolff-Parkinson-White syndrome. 
c. In the patient with long QT intervals. 
d. In the patient with documented significant aortic valve 
disease and symptoms suggestive of arrhythmia. 
e. In the patient with dilated cardiomyopathy and symp- 
toms suggestive of arrhythmia. 
Class III 
a. In the patient with known stable coronary artery 
disease without evidence for myocardial dysfunction or 
arrhythmia. 
b. In the person with asymptomatic mitral valve pro- 
lapse. 
c. In the asymptomatic person without known heart 
disease about to embark on an exercise program. 
d. In the asymptomatic person who requires assessment 
of risk for potentially disabling arrhythmias because his or 
her occupation might place others in jeopardy if an arrhyth- 
mia were to occur. 
D. Assessment of Eficacy of 
Antiarrhythmic Therapy 
General considerations 
The use of ambulatory electrocardiography to assess 
antiarrhythmic drug therapy is based on the assumption that 
a decrease in the frequency of arrhythmias is associated with 
either a decrease in symptomatic events or improved sur- 
vival. There has not been agreement as to the specific 
magnitude of reduction in the frequency of arrhythmia that 
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predicts a decrease in cardiac events. Hence, ambulatory 
ECG criteria for assessment of the efficacy of antiarrhythmic 
therapy are arbitrary (16-21). Because there are wide varia- 
tions in the frequency of arrhythmias without therapy. a 
change in frequency must be of major magnitude before 
efficacy can be inferred. To permit appropriate assessment 
of therapeutic efficacy and detection of proarrhythmic effect, 
both the pretreatment frequency and the complexity of 
ectopic activity must be recorded before and during therapy 
and the patient needs to serve as his or her own control (1% 
22). Furthermore, the time intervals between recordings may 
be critical (23,24). 
Specific considerations 
Premature ventricular complexes. Analysis of premature 
ventricular complexes must incorporate consideration of the 
substantial amount of spontaneous variation in frequency 
that occurs without therapy (25,26). Hence, drug efficacy has 
been defined as a minimum of 50, 80 or 90% reduction in 
ventricular premature complex frequency when comparing 
the pre and post-treatment 24 h ambulatory recording peri- 
ods (17,19). The degree of reduction required depends on the 
number of recordings obtained to establish spontaneous 
variability, the population examined and the malignancy of 
the arrhythmias. The arbitrary definition of “reduced” ec- 
topic activity has to be viewed within the contexts of the 
clinical and baseline frequency. At one end of the spectrum 
is absence of symptoms, no history of heart disease and 
uniform and relatively infrequent premature ventricular 
complexes for which no ambulatoI’y assessment is required. 
As each of these factors increases in severity or frequency. 
the risk of a cardiac event increases. There are as yet no 
universally accepted algorithms for integrating this multivar- 
iate information into a reliable statement of risk for an 
individual patient. For this reason although ambulatory 
electrocardiography is frequently used to assess pharmaco- 
logic efficacy in the suppression of premature ventricular 
complexes, there is no agreement on this practice with 
respect to indications or utility. When the arrhythmias are of 
high frequency and are reproducible. however, ambulatory 
electrocardiography may be useful in such assessment. 
Ventricular tachycardia. Patients with episodic ventricu- 
lar tachycardias are candidates for ambulatory electrocardi- 
ography if drugs are to be used for arrhythmia control. 
Current data suggest that among patients experiencing “ma- 
lignant ventricular arrhythmia” (sustained symptomatic ven- 
tricular tachycardia, for example, or ventricular fibrillation 
unrelated to acute myocardial infarction, there are sub- 
groups in whom improved outcome is predicted when there 
is either a marked reduction in premature ventricular com- 
plexes or ventricular couplets or ablation of nonsustained 
salvos of ventricular tachycardia, or both (19-21). Con- 
versely. withdrawal of antiarrhythmic drugs from patients 
with a malignant ventricular arrhythmia has been reported to 
be associated with recurrence of the arrhythmia (27). 
Supraventricular arrhythmias. There are few reports 
analogous to those concerning ventricular arrhythmias that 
assess the relation between percent reduction in supraven- 
tricular arrhythmias and subsequent clinical outcome. Be- 
cause permanently disabling events are not commonly asso- 
ciated with the supraventricular tachycardias. amelioration 
of symptoms usually is considered to be a sufficient criterion 
for therapeutic efficacy. In light of the high risk for systemic 
emboli, atrial fibrillation may be an atria1 arrhythmia that 
even during asymptomatic periods requires assessment of 
therapeutic efficacy. Among such patients, particularly if 
they are not receiving anticoagulant agents, documentation 
of the suppression of atrial fibrillation paroxysms by anti- 
arrhythmic drugs is an indication for ambulatory electrocar- 
diography. A second condition for which some believe 
supraventricular arrhythmia suppression should be assessed 
is the Wolff-Parkinson-White syndrome. 
Classification of indications for ambulatory 
electrocardiography to assess efficacy of therapy 
Class I 
In patients with baseline high frequency. reproducible, 
sustained, symptomatic premature ventricular complexes. 
supraventricular arrhythmias or ventricular tachycardia. 
Class II 
a. In patients with known episodic or reverted atria1 
fibrillation to determine efficacy of arrhythmia control. 
b. In patients with premature ventricular complexes of 
variable frequency and complexity or relatively infrequent 
brief salvos of ventricular or supraventricular arrhythmias. 
c. In patients with the Wolff-Parkinson-White syndrome. 
d. For the assessment of proarrhythmia effects. 
e. For the assessment of tachycardias, bradycardias and 
conduction defects related to drug administration. 
Class III 
None. 
General considerations 
The assessment of pacemaker function during a patient’s 
normal daily activities often is essential for proper manage- 
ment. Because of the limited time of examination provided 
by the traditional pacemaker follow-up clinic visit and trans- 
telephonic monitoring systems, the use of ambulatory elec- 
trocardiography for pacemaker evaluation over 224 h during 
daily activities has increased the diagnostic yield in the 
detection of pacemaker dysfunction (28). Enhanced detec- 
tion of pacemaker dysfunction by ambulatory electrocardi- 
ography also has proven valuable in the early postimplanta- 
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tion period when compared with in-hospital telemetry 
monitoring (29). This increased diagnostic yield is not related 
simply to more prolonged time of examination. It has been 
facilitated by ambulatory ECG technology that permits 
detection and recognition of the pacing stimulus artifact 
through its amplification and recording on a separate dedi- 
cated channel (30-32). Current technology can automatically 
provide information concerning failure to capture, failure to 
sense, failure to generate an impulse, number of pacing 
stimuli and percent of beats paced. Although currently 
reliable for single chamber pacemakers, the technology 
needs additional refinement for the automatic evaluation of 
dual-chamber pacemakers. Ambulatory electrocardiography 
is of value, however, in the presence of dual-chamber 
pacemakers by making possible the visual interpretation of 
the ECG during daily activities. 
Classification of indications for ambulatory 
electrocardiography to assess pacemaker function 
Class I 
a. Evaluation of paroxysmal symptoms in patients with 
pacemakers. 
b. Detection of myopotential inhibition. 
c. Detection of pacemaker mediated tachycardia. 
d. Evaluation of antitachycardia pacing device function- 
ing. 
e. Evaluation of rate-responsive physiologic pacing 
function. 
Class II 
a. Routine pacemaker follow-up evaluation. 
b. Evaluation of atria1 and/or ventricular sensing and 
pacing immediately after implantation of either dual- or 
single-chamber pacing devices. 
c. Evaluation of percent of time pacemaker is functioning 
and utilized in a 24 h day. 
d. Evaluation of rate and supraventricular arrhythmias in 
patients with implanted defibrillators. 
Class III 
Evaluation of pacemaker failure identified by standard 
ECG or pacing surveillance instrumentation, or both. 
F. Detection of Myocardial Ischemia 
General considerations 
The application of ambulatory electrocardiography for 
the detection of myocardial ischemia is more recent than its 
use in arrhythmia detection and classification. The develop- 
ment was slowed by technical considerations that increased 
the complexity of the instrumentation required for accurate 
measurement of ST segment deviation. There is now con- 
vincing evidence that ST segment shifts of the ischemic type 
can be detected by ambulatory electrocardiography and 
assessed provided that the total system instrumentation from 
recorder through the analysis and playback components is 
adequate, and 2) developments in instrumentation are pro- 
gressing rapidly in response to the growing clinical interest in 
ischemia not associated with angina (asymptomatic ische- 
mia) (33-40). Instrumentation is evolving that is capable of 
examining two or more channels of data for changes in 
magnitude, integral area and shape of the ST segment. 
Predictive value. The predictive value of the ambulatory 
ECG for the detection of ischemia depends on the sensitivity 
and specificity of the test as well as the prevalence of the 
disease in the population being tested. The predictive value 
is low in asymptomatic patients without documented coro- 
nary artery disease primarily because many physiologic and 
technical factors that can alter the ST segment are unrelated 
to ischemia and, therefore, result in false positive tests. In 
the presence of coronary artery disease, the predictive value 
for ischemia may be high in patients with typical angina, 
because, as is the case with the exercise ECG, the concom- 
itant occurrence of ST segment changes and typical angina 
increases the specificity of the test. 
Analysis and interpretation of ST segment deviation. Re- 
polarization and, thus, ST segment configuration, may be 
altered by physiologic events other than ischemia, and these 
may occur with some frequency and to a changing degree in 
the ambulatory patient with coronary artery disease (pos- 
tural changes, tachycardia, hypertension, sympathetic ner- 
vous system discharge, hyperventilation, left ventricular 
dimension and pressure changes, alterations in intraventric- 
ular conduction and drug level fluctuations). Therefore, the 
criteria for ischemic ST segment changes on the ambulatory 
ECG must be interpreted with great care to preclude false 
negative test results. ST segment evaluation, when used for 
research purposes where the instrumentation is accurate, the 
findings compulsively validated and the clinical variables 
recognized or controlled, is providing useful information. 
The significance of ischemic-type ST change, whether 
caused by ischemia or other factors altering repolarization as 
an independent risk factor, is under investigation (38-40), as 
is the use of the ST segment as a method to assess the 
efficacy of antiischemic therapy. The data relative to the 
technical and clinical criteria that must be met to assure 
appropriate clinical application of the findings from such 
studies are in rapid evolution and will facilitate utilization of 
ambulatory electrocardiography for the detection of ische- 
mia, evaluation of therapy and risk prediction. 
The Subcommittee consensus at the present time is that 
further data relative to the utility of ST segment analyses for 
the evaluation of myocardial ischemia are required to pre- 
vent misuse of this important technology. Although there is 
increasing evidence that the information derived from am- 
bulatory electrocardiography will be important in the man- 
agement of ischemic heart disease, the Subcommittee has 
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chosen a conservative approach until such time as the 
studies are more widely confirmed. 
Classification of indications for ambulatory 
electrocardiography for the detection of ischemia in 
patients with chest pain 
Class I 
Patients with chest pain suggestive of Prinzmetal’s an- 
gina. In this group, ambulatory electrocardiography may 
demonstrate characteristic ST segment elevation at the time 
of chest pain and thus establish the diagnosis. 
Class II 
Symptomatic patients who are unable to be tested by 
treadmill or bicycle. Ambulatory electrocardiography can 
document ST segment shifts accompanying episodes of 
chest pain provoked by everyday stresses. 
Class III 
a. Patients whose description of chest pain is classic for 
angina pectoris and who have one or more risk factors for 
coronary artery disease. The diagnosis of angina pectoris is 
almost certain in such patients, and its probability is unlikely 
to be improved further by ambulatory electrocardiography. 
b. Patients with atypical chest pain and one or more risk 
factors. In this group the diagnosis of angina pectoris is 
highly uncertain, and ambulatory electrocardiography is not 
the diagnostic procedure of choice. 
c. Patients with chest pain atypical for myocardial ische- 
mia in the absence of coronary artery disease risk factors. 
Ischemia as a basis for chest pain is very unlikely in these 
patients, and ambulatory electrocardiography is not the 
diagnostic procedure of choice. 
Classification of indications for ambulatory 
electrocardiography for the detection of ischemia in 
the asymptomatic individual 
Class I 
None 
Class II 
None. 
Class III 
a. Primary detection of ischemia in the asymptomatic 
individual with known risk factors for coronary artery dis- 
ease. There is increased probability of ischemia, but ambu- 
latory electrocardiography is not the diagnostic procedure of 
choice. 
b. Detection of ischemia in the asymptomatic individual 
without identifiable coronary artery disease risk factors. 
Ischemia is very unlikely and ambulatory electrocardiog- 
raphy is not the procedure of choice. 
Classification of indications for ambulatory 
electrocardiography for the primary detection of 
asymptomatic ischemia in the patient with known 
coronary artery disease 
Class I 
Class II 
a. Postmyocardial infarction patients who have been 
known to have premature ventricular complexes. Some 
clinicians are employing ambulatory electrocardiography to 
determine whether ST segment changes and ventricular 
arrhythmias occur simultaneously because this combination 
is thought to confer increased risk of death. 
b. Patients with chronic stable angina to assess efficacy 
of antiischemic therapy. Some clinicians are employing 
ambulatory electrocardiography to determine whether a 
patient’s therapeutic regimen is satisfactorily suppressing 
asymptomatic ischemia. 
Class III 
a. For routine use after myocardial infarction. 
b. For routine use in the post revascularization patient. 
either after percutaneous transluminal coronary angioplasty 
or after coronary artery bypass grafting. 
c. For patients entering a cardiovascular rehabilitation 
program. 
Classification of indications for ambulatory 
electrocardiography to assess risk of future 
cardiac events 
Class I 
None. 
Class II 
For risk prediction in patients with known coronary 
artery disease, anterior myocardial infarction and stable or 
unstable angina when combined with confirmatory stress 
testing. 
Class III 
For risk prediction when used as a sole test. 
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